Revisiting the role of Substance P and CGRPα
Open Access
- 16 April 2025
- journal article
- editorial
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Abstract
Mice lacking two neuropeptides thought to be essential for processing pain show no change in how they respond to a wide range of harmful stimuli.Keywords
This publication has 10 references indexed in Scilit:
- Pain persists in mice lacking both Substance P and CGRPα signalingeLife, 2025
- A Female-Specific Role for Calcitonin Gene-Related Peptide (CGRP) in Rodent Pain ModelsThe Journal of Neuroscience, 2022
- Targeting calcitonin gene-related peptide: a new era in migraine therapyThe Lancet, 2019
- Substance P and pain chronicityCell and tissue research, 2018
- Overview of Neuropeptides: Awakening the Senses?Headache: The Journal of Head and Face Pain, 2017
- Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in αCGRP-deficient miceNature Neuroscience, 2001
- Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxoneBrain Research, 2000
- NK1 (substance P) receptor antagonists – why are they not analgesic in humans?Trends in Pharmacological Sciences, 2000
- Null Mutations Lacking Substance: Elucidating Pain Mechanisms by Genetic PharmacologyNeuron, 1998
- Primary afferent tachykinins are required to experience moderate to intense painNature, 1998